Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronochemotherapy: L 1210 leukemia and beyond.

F Halberg, W Nelson, G Cornélissen

    Chronobiologia
    |July 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Creatinine clearance and blood pressure: a 34-year circadian study.

    La Clinica terapeutica·2009
    Same author

    Why continued surveillance? Intermittent blood pressure and heart rate abnormality under treatment.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2005
    Same author

    Circadian rhythms of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), cortisol, and melatonin in women with breast cancer.

    Chronobiology international·2001
    Same author

    Circadian rhythms and clinical medicine with applications to hypertension.

    American journal of hypertension·2001
    Same author

    Alterations with aging of the endocrine and neuroendocrine circadian system in humans.

    Chronobiology international·2000
    Same author

    Melatonin levels in women with fibromyalgia and chronic fatigue syndrome.

    The Journal of rheumatology·1999
    Same journal

    Models for chronobiologic risk and prepathology detection. A tribute to Bill W. Kennedy.

    Chronobiologia·1994
    Same journal

    Dora K. (Holly) Hayes.

    Chronobiologia·1994
    Same journal

    Agostino Carandente.

    Chronobiologia·1994
    Same journal

    In defense of proper cosinor analysis.

    Chronobiologia·1994
    Same journal

    "Cancer marker chronomes" assessed in the light of chronobioethics.

    Chronobiologia·1994
    Same journal

    Cardiovascular disease risk monitoring in the light of chronobioethics.

    Chronobiologia·1994
    See all related articles

    Cancer chronotherapy shows statistically significant benefits over homeostatic therapy when cure rates are considered in survival time analysis. This approach improves interpretation of therapeutic research data.

    Area of Science:

    • Oncology
    • Pharmacology
    • Biostatistics

    Background:

    • Interpreting median survival times in cancer research is complex.
    • The impact of potential cures on survival data requires careful consideration.
    • Existing therapeutic strategies include homeostatic therapy.

    Purpose of the Study:

    • To evaluate the efficacy of cancer chronotherapy versus homeostatic therapy.
    • To incorporate cure rates into the analysis of median survival times.
    • To provide statistically significant evidence for therapeutic approaches in oncology.

    Main Methods:

    • Analysis of recently published therapeutic research data.
    • Statistical interpretation of median survival times.
    • Comparative analysis of chronotherapy and homeostatic therapy outcomes, accounting for cure rates.

    Related Experiment Videos

    Main Results:

    • Statistically significant evidence favors cancer chronotherapy.
    • Inclusion of cure rates refines the interpretation of survival data.
    • Chronotherapy demonstrates superior outcomes compared to homeostatic therapy in the analyzed data.

    Conclusions:

    • Cancer chronotherapy is a more effective treatment strategy than homeostatic therapy when cure is considered.
    • Median survival time interpretation in therapeutic research must account for cure.
    • Further research into chronotherapy is warranted for improved cancer treatment.